Gemmer Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-109
| Closed | -$19K | – | 1089 |
|
|
2022
Q1 | $19K | Hold |
109
| – | – | ﹤0.01% | 514 |
|
|
2021
Q4 | $24K | Hold |
109
| – | – | ﹤0.01% | 458 |
|
|
2021
Q3 | $20K | Hold |
109
| – | – | ﹤0.01% | 483 |
|
|
2021
Q2 | $20K | Hold |
109
| – | – | ﹤0.01% | 536 |
|
|
2021
Q1 | $18K | Hold |
109
| – | – | ﹤0.01% | 548 |
|
|
2020
Q4 | $17K | Hold |
109
| – | – | ﹤0.01% | 506 |
|
|
2020
Q3 | $11K | Buy |
109
+3
| +3% | +$329 | ﹤0.01% | 586 |
|
|
2020
Q2 | $13K | Buy |
106
+17
| +19% | +$1.91K | ﹤0.01% | 516 |
|
|
2020
Q1 | $8K | Hold |
89
| – | – | ﹤0.01% | 618 |
|
|
2019
Q4 | $8K | Hold |
89
| – | – | ﹤0.01% | 761 |
|
|
2019
Q3 | $7K | Sell |
89
-44
| -33% | -$3.54K | ﹤0.01% | 836 |
|
|
2019
Q2 | $10K | Buy |
133
+24
| +22% | +$2.24K | ﹤0.01% | 668 |
|
|
2019
Q1 | $13K | Buy |
109
+1
| +0.9% | +$117 | ﹤0.01% | 581 |
|
|
2018
Q4 | $12K | Hold |
108
| – | – | ﹤0.01% | 552 |
|
|
2018
Q3 | $14K | Hold |
108
| – | – | ﹤0.01% | 552 |
|
|
2018
Q2 | $12K | Hold |
108
| – | – | ﹤0.01% | 629 |
|
|
2018
Q1 | $12K | Sell |
108
-9
| -8% | -$1.14K | ﹤0.01% | 621 |
|
|
2017
Q4 | $17K | Hold |
117
| – | – | 0.01% | 493 |
|
|
2017
Q3 | $14K | Hold |
117
| – | – | 0.01% | 532 |
|
|
2017
Q2 | $15K | Hold |
117
| – | – | 0.01% | 490 |
|
|
2017
Q1 | $16K | Hold |
117
| – | – | 0.01% | 444 |
|
|
2016
Q4 | $17K | Buy |
117
+3
| +3% | +$383 | 0.01% | 398 |
|
|
2016
Q3 | $13K | Hold |
114
| – | – | 0.01% | 490 |
|
|
2016
Q2 | $12K | Hold |
114
| – | – | 0.01% | 487 |
|
|
2016
Q1 | $12K | Sell |
114
-11
| -9% | -$1.39K | 0.01% | 480 |
|
|
2015
Q4 | $20K | Buy |
125
+12
| +11% | +$1.75K | 0.01% | 306 |
|
|
2015
Q3 | $15K | Buy |
113
+6
| +6% | +$962 | 0.01% | 408 |
|
|
2015
Q2 | $19K | Hold |
107
| – | – | 0.01% | 339 |
|
|
2015
Q1 | $18K | Hold |
107
| – | – | 0.01% | 374 |
|
|
2014
Q4 | $81K | Hold |
107
| – | – | 0.05% | 120 |
|
|
2014
Q3 | $14K | Hold |
107
| – | – | 0.01% | 424 |
|
|
2014
Q2 | $9K | Hold |
107
| – | – | 0.01% | 662 |
|
|
2014
Q1 | $10K | Buy |
+107
| New | +$10.9K | 0.01% | 592 |
|
Other funds holding UTHR
ACA
APM
Gemmer Asset Management's UTHR Position: Q2 2022 in Review
Gemmer Asset Management sold out of United Therapeutics (UTHR) in Q2 2022, closing a stake of 109 shares — an estimated $19K sold.
Gemmer Asset Management first reported a position in UTHR in Q1 2014 and held it in 33 quarters. The position peaked at $81K in Q4 2014. 472 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.
- Gemmer Asset Management reported no remaining United Therapeutics position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 109 United Therapeutics shares in Q2 2022, an estimated $19K.
- Gemmer Asset Management first reported a position in United Therapeutics in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's United Therapeutics position peaked at $81K in Q4 2014.
- 472 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.